EP Patent

EP3456329A1 — Improved testosterone gel and method of use

Assigned to Besins Healthcare Luxembourg SARL · Expires 2019-03-20 · 7y expired

What this patent protects

The present invention relates to an improved transdermal hydroalcoholic testosterone gel formulation that provides, among other things, a desirable pharmacokinetic hormone profile, and methods of use.

USPTO Abstract

The present invention relates to an improved transdermal hydroalcoholic testosterone gel formulation that provides, among other things, a desirable pharmacokinetic hormone profile, and methods of use.

Drugs covered by this patent

Patent Metadata

Patent number
EP3456329A1
Jurisdiction
EP
Classification
—
Expires
2019-03-20
Drug substance claim
No
Drug product claim
No
Assignee
Besins Healthcare Luxembourg SARL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.